How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment Patrick Branch Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 10262020171026
Special Report MedTech Unlocking the Value of Quality Next-Generation Sequencing in APAC November 17, 2022
Article Life Sciences & Pharma Advancement in Antimicrobial Resistance Management in Asia Pacific July 12, 2022
Executive Insights Life Sciences & Pharma Looking Ahead in Pharma Services: Key Trends Impacting the Industry April 14, 2022